Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.17 USD | +1.13% | -2.62% | -23.37% |
Jun. 07 | Mizuho Initiates Chemours With Neutral Rating, $25 Price Target | MT |
Jun. 05 | Industrials Advance as Fed Hopes Offset Economic Fears - Industrials Roundup | DJ |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company is in debt and has limited leeway for investment
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.37% | 3.6B | C+ | ||
+4.88% | 77.85B | B | ||
-4.94% | 45.15B | A- | ||
+4.00% | 33.45B | C | ||
+16.46% | 19.03B | B | ||
+15.01% | 12.15B | A- | ||
-2.61% | 10.56B | - | ||
-21.73% | 10.17B | B | ||
-1.35% | 9.08B | A- | ||
-4.87% | 8.2B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CC Stock
- Ratings The Chemours Company